NCT01570764 Cyclophosphamide Systemic Sclerosis Associated Interstitial Lung Disease Status COMPLETED Phase PHASE3
NCT01569204 Targeted BEACOPP Variants in Patients With Newly Diagnosed Advanced Classical Hodgkin Lymphoma Status COMPLETED Phase PHASE2
NCT01554371 Eribulin in Combination With Cyclophosphamide in Patients With Solid Tumor Malignancies Status COMPLETED Phase PHASE1/PHASE2
NCT01548573 Tandem Auto Transplantation in Myeloma Patients With <12 Months of Prior Treatment Status TERMINATED Phase PHASE2
NCT01547741 Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer Status UNKNOWN Phase PHASE3
NCT01539902 Phase 2 Study of Human Umbilical Cord Derived Mesenchymal Stem Cell for the Treatment of Lupus Nephritis Status UNKNOWN Phase PHASE2
NCT01539174 Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated High- or High-Intermediate-Risk Diffuse Large B-Cell Lymphoma Status WITHDRAWN Phase PHASE2
NCT01537861 Filgrastim in Treating Patients With Bortezomib-, Carfilzomib-, or IMID-Refractory Multiple Myeloma Status TERMINATED Phase EARLY_PHASE1
NCT01537029 Effect of Weight on the Population Pharmacokinetic Analysis of Doxorubicin and Cyclophosphamide Status COMPLETED Phase PHASE4
NCT01527487 Trial of Eribulin/Cyclophosphamide or Docetaxel/Cyclophosphamide as Neoadjuvant Therapy in Locally Advanced HER2-Negative Breast Cancer Status COMPLETED Phase PHASE2
NCT01527149 Ofatumumab in Combination With Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine Sulfate, and Dexamethasone Alternating With Ofatumumab in Combination With Cytarabine and Methotrexate in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma Status COMPLETED Phase PHASE2
NCT01516307 Trial of Active Immunotherapy With Globo H-KLH (OPT-822) in Metastatic Breast Cancer Subjects Status COMPLETED Phase PHASE2
NCT01509300 HLA-haploidentical Hematopoietic Stem Cell Transplantation for Children and Adolescents With Acute Leukemia, Myelodysplastic Syndrome and Solid Tumors Status UNKNOWN Phase PHASE1/PHASE2
NCT01503905 Neoadjuvant Chemotherapy for Operable Premenopausal Breast Cancer Patients Status UNKNOWN Phase NA
NCT01498588 Trial of Eribulin Followed by Doxorubicin & Cyclophosphamide for Her2-negative, Locally Advanced Breast Cancer Status TERMINATED Phase PHASE2
NCT01495572 Melanoma Treatment With White Blood Cells That Destroy MART Expressing Tumor Cells Status TERMINATED Phase PHASE2